From left, GC Therapeutics co-founders Parastoo Khoshakhlagh, Alex Ng, and George Church.Courtesy GC Therapeutics

By Allison DeAngelis

Sept. 19, 2024

Biotech Startups and Venture Capital Reporter

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally. 

Church, the enigmatic founder behind companies including eGenesis, Editas Medicine, and Colossal Biosciences, donated some of his own skin cells for use at his new startup GC Therapeutics. (And yes, the letters in the company’s name stand for “George Church.”) 

advertisement

The company, which launched on Thursday, envisions turning induced pluripotent stem cells into cells found in the nervous, immune, and gastrointestinal systems for new off-the-shelf therapies. 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
,
Submit a correction requestReprints

  1. Allison DeAngelis

    Biotech Startups and Venture Capital Reporter

    Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.